Latest fiscal year 2025 · computed deterministically from XBRL 10-K data · coverage 100%
In fiscal 2025, STRATA CRITICAL MEDICAL, INC. reported revenue of $197M, up 34.3% year over year. Operating margin was -11.3% and net margin 21.0%, on a free-cash-flow margin of -29.7% with capital expenditure at 4.9% of revenue. Every figure is computed directly from SRTA's SEC XBRL 10-K filing — deterministic, with no estimates.
| Fiscal year | Revenue | Op margin | Net margin |
|---|---|---|---|
| FY2025 | $197M | -11.3% | 21.0% |
| FY2024 | $147M | -15.3% | -18.6% |
| FY2023 | $225M | -30.3% | -24.9% |
| FY2022 | $146M | -36.6% | -18.7% |
| FY2021 | $51M | -47.7% | -79.3% |
How does SRTA compare against its actual peer set?
A CompsDesk subscription covers unlimited benchmark packs on any covered company: up to 19 metrics (6 core guaranteed) × up to 5 fiscal years × up to 12 chosen peers, percentile placement, the subject's figures cited to their SEC tag, form and period with every company identified by its CIK, PDF-ready HTML + CSV, generated on demand.
Related in the same sector: AACG · ABSI · ACCS · ACHC · ACM · ADUS
Source: SEC EDGAR XBRL (10-K filings), latest filed values. "n/a" = not disclosed under mapped tags — never estimated. Informational benchmarking, not investment advice. © CompsDesk / Sam Arora.